SCHEMBL12374615

SCHEMBL12374615

CC1(C)OC2C(CO[Si](C)(C)C(C)(C)C)OC(n3ccc4c(Cl)nc(N)nc43)C2O1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.39
P2RX1 P51575 1/20 0.36
P2RX3 P56373 1/20 0.36
P2RX4 Q99571 1/20 0.36
PI4KA P42356 1/20 0.35
PI4K2B Q8TCG2 1/20 0.35
PI4K2A Q9BTU6 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
APOBEC3G Q9HC16 1/20 0.33
NT5E P21589 4/20 0.33
PRMT5 O14744 4/20 0.33
WDR77 Q9BQA1 3/20 0.33
DUT P33316 1/20 0.32
HSP90AA1 P07900 2/20 0.31
HDAC6 Q9UBN7 1/20 0.31
AMD1 P17707 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25354004 1.00 RXFP1 (0.39) RXFP1P2RX1P2RX3P2RX4PI4KA
SCHEMBL22334000 1.00 RXFP1 (0.39) RXFP1P2RX1P2RX3P2RX4PI4KA
SCHEMBL18572203 0.91 RXFP1 (0.34) RXFP1P2RX1P2RX3P2RX4PI4KA
SCHEMBL18572819 0.90 PRMT5 (0.34) RXFP1P2RX1P2RX3P2RX4PI4KA
SCHEMBL31526129 0.89 RXFP1 (0.33) RXFP1P2RX1P2RX3P2RX4PI4KA
SCHEMBL21839614 0.89 NT5E (0.37) RXFP1P2RX1P2RX3P2RX4PI4KA
SCHEMBL21883347 0.89 NT5E (0.37) RXFP1P2RX1P2RX3P2RX4PI4KA
SCHEMBL18009694 0.85 RXFP1 (0.41) RXFP1P2RX1P2RX3P2RX4PI4KA
SCHEMBL24687531 0.85 RXFP1 (0.41) RXFP1P2RX1P2RX3P2RX4PI4KA
SCHEMBL10131056 0.85 RXFP1 (0.41) RXFP1P2RX1P2RX3P2RX4PI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003769-B2 Dye-labeled ribonucleotide triphosphates APPLIED BIOSYSTEMS, LLC (US) 2011-08-23 US disclosed
US-8003769-B2 Dye-labeled ribonucleotide triphosphates APPLIED BIOSYSTEMS, LLC (US) 2011-08-23 US disclosed
US-20100292457-A1 Dye-labeled ribonucleotide triphosphates APPLIED BIOSYSTEMS, LLC (US) 2010-11-18 US disclosed
US-20100292457-A1 Dye-labeled ribonucleotide triphosphates APPLIED BIOSYSTEMS, LLC (US) 2010-11-18 US disclosed
US-7678892-B2 Dye-labeled ribonucleotide triphosphates APPLIED BIOSYSTEMS, LLC (US) 2010-03-16 US disclosed
US-7678892-B2 Dye-labeled ribonucleotide triphosphates APPLIED BIOSYSTEMS, LLC (US) 2010-03-16 US disclosed
US-20070293662-A1 Dye-labeled ribonucleotide triphosphates APPLERA CORPORATION (US) 2007-12-20 US disclosed
US-20070293662-A1 Dye-labeled ribonucleotide triphosphates APPLERA CORPORATION (US) 2007-12-20 US disclosed
US-7262029-B2 Dye-labeled ribonucleotide triphosphates APPLERA CORPORATION (US) 2007-08-28 US disclosed
US-7262029-B2 Dye-labeled ribonucleotide triphosphates APPLERA CORPORATION (US) 2007-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292457-A1 Dye-labeled ribonucleotide triphosphates DUT, POLRMT, SAMHD1 RXFP1 2880/4885P2RX1 643/4885P2RX3 508/4885
US-20070293662-A1 Dye-labeled ribonucleotide triphosphates DUT, POLRMT, SAMHD1 RXFP1 2880/4885P2RX1 643/4885P2RX3 508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.